• Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=24336076).
  

PubMed=9349880; DOI=10.3109/00016489709113477
Kim S.Y., Chu K.-C., Lee H.R., Lee K.-S., Carey T.E.
Establishment and characterization of nine new head and neck cancer cell lines.
Acta Oto-Laryngol. 117:775-784(1997)

PubMed=11039880; DOI=10.1080/000164800750000513
Kim S.H., Carey T.E., Liebert M., Yoo S.J., Kwon H.J., Kim S.Y.
Characterization of AMC-HN-9, a cell line established from an undifferentiated carcinoma of the parotid gland: expression of alpha6beta4 with the absence of BP180 and 230.
Acta Oto-Laryngol. 120:660-666(2000)

PubMed=24336076; DOI=10.1038/cddis.2013.488; PMCID=PMC3877559
Roh J.-L., Kim E.H., Park H.B., Park J.Y.
The Hsp90 inhibitor 17-(allylamino)-17-demethoxygeldanamycin increases cisplatin antitumor activity by inducing p53-mediated apoptosis in head and neck cancer.
Cell Death Dis. 4:e956.1-e956.8(2013)